Wie wirksam ist intensive Aphasietherapie unter regulären klinischen Bedingungen? Die deutschlandweite Aphasieversorgungsstudie FCET2EC

Translated title of the contribution: How effective is intensive aphasia therapy under routine clinical conditions? the German randomised controlled multicentre trial FCET2EC

C. Breitenstein*, T. Grewe, A. Flöel, W. Ziegler, L. Springer, P. Martus, A. Baumgärtner

*Corresponding author for this work
5 Citations (Scopus)

Abstract

The multicentre study FCET2EC (from controlled experimental trial to=2 everyday communication) is internationally the first randomised waiting list controlled trial to determine the effectiveness of intensive language therapy in stroke patients with chronic aphasia (i. e., persisting longer than 6 months after the initial stroke). This study examines at a high methodological level (evidence class 1) whether integrative intensive language and communication therapy, administered under routine clinical conditions, leads to improved everyday communication (and thus less morbidity) as well as to improved health-related quality of life. A secondary research question is the stability of the expected effects over the course of 6 months. Randomised controlled clinical trials, such as the one proposed here, are urgently needed to provide the basis for evidence-based interventions in patients with chronic aphasia.

Translated title of the contributionHow effective is intensive aphasia therapy under routine clinical conditions? the German randomised controlled multicentre trial FCET2EC
Original languageGerman
JournalSprache Stimme Gehor
Volume38
Issue number1
Pages (from-to)14-19
Number of pages6
ISSN0342-0477
DOIs
Publication statusPublished - 03.2014

Research Areas and Centers

  • Health Sciences

DFG Research Classification Scheme

  • 2.23-08 Human Cognitive and Systems Neuroscience
  • 2.23-07 Clinical Neurology, Neurosurgery and Neuroradiology

Fingerprint

Dive into the research topics of 'How effective is intensive aphasia therapy under routine clinical conditions? the German randomised controlled multicentre trial FCET2EC'. Together they form a unique fingerprint.

Cite this